These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 17531210)

  • 21. Sarcoplasmic reticulum Ca2+ leak in heart failure: mere observation or functional relevance?
    George CH
    Cardiovasc Res; 2008 Jan; 77(2):302-14. PubMed ID: 18006486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiac failure in ruminants caused by gousiekte.
    Pretorius PJ; Terblanche M; Van Der Walt JD; Van Ryssen JC
    Recent Adv Stud Cardiac Struct Metab; 1973; 2():385-97. PubMed ID: 4806974
    [No Abstract]   [Full Text] [Related]  

  • 23. Activation of Na+/H+ exchanger 1 is sufficient to generate Ca2+ signals that induce cardiac hypertrophy and heart failure.
    Nakamura TY; Iwata Y; Arai Y; Komamura K; Wakabayashi S
    Circ Res; 2008 Oct; 103(8):891-9. PubMed ID: 18776042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abnormal biochemistry in myocardial failure.
    Schwartz A; Sordahl LA; Entman ML; Allen JC; Reddy YS; Goldstein MA; Luchi RJ; Wyborny LE
    Am J Cardiol; 1973 Sep; 32(4):407-22. PubMed ID: 4354110
    [No Abstract]   [Full Text] [Related]  

  • 25. Myocyte death and growth in the failing heart.
    Anversa P; Leri A; Beltrami CA; Guerra S; Kajstura J
    Lab Invest; 1998 Jul; 78(7):767-86. PubMed ID: 9690556
    [No Abstract]   [Full Text] [Related]  

  • 26. Diastolic release of calcium from the sarcoplasmic reticulum: a potential target for treating triggered arrhythmias and heart failure.
    Shannon TR; Lew WY
    J Am Coll Cardiol; 2009 May; 53(21):2006-8. PubMed ID: 19460615
    [No Abstract]   [Full Text] [Related]  

  • 27. Getting energy to where it is required is a problem in the failing heart.
    Barclay CJ
    J Physiol; 2008 Nov; 586(21):5037-8. PubMed ID: 18978158
    [No Abstract]   [Full Text] [Related]  

  • 28. Resident cardiac mast cells: are they the major culprit in the pathogenesis of cardiac hypertrophy?
    Balakumar P; Singh AP; Ganti SS; Krishan P; Ramasamy S; Singh M
    Basic Clin Pharmacol Toxicol; 2008 Jan; 102(1):5-9. PubMed ID: 17973902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypothesis: apoptosis may be a mechanism for the transition to heart failure with chronic pressure overload.
    Bing OH
    J Mol Cell Cardiol; 1994 Aug; 26(8):943-8. PubMed ID: 7799449
    [No Abstract]   [Full Text] [Related]  

  • 30. [Proteins and nucleic acids in the chronicly insufficient myocardium].
    Nowy H
    Verh Dtsch Ges Kreislaufforsch; 1968; 34():184-6. PubMed ID: 4242129
    [No Abstract]   [Full Text] [Related]  

  • 31. [Reduction of microsomal phospholipids in experimental cardiac decompensation (rat heart-lung preparation)].
    Panagia V; Minelli R; Zonta F
    Farmaco Sci; 1971 Nov; 26(11):1006-14. PubMed ID: 5143141
    [No Abstract]   [Full Text] [Related]  

  • 32. Crosstalk between L-type Ca2+ channels and the sarcoplasmic reticulum: alterations during cardiac remodelling.
    Bito V; Heinzel FR; Biesmans L; Antoons G; Sipido KR
    Cardiovasc Res; 2008 Jan; 77(2):315-24. PubMed ID: 18006436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Another calcium paradox in heart failure.
    Kass RS; Lindegger N; Hagen B; Lederer WJ
    J Mol Cell Cardiol; 2008 Jul; 45(1):28-31. PubMed ID: 18504047
    [No Abstract]   [Full Text] [Related]  

  • 34. On the control of metabolic remodeling in mitochondria of the failing heart.
    Ingwall JS
    Circ Heart Fail; 2009 Jul; 2(4):275-7. PubMed ID: 19808349
    [No Abstract]   [Full Text] [Related]  

  • 35. Electrophysiological remodeling in hypertrophy and heart failure.
    Tomaselli GF; Marbán E
    Cardiovasc Res; 1999 May; 42(2):270-83. PubMed ID: 10533566
    [No Abstract]   [Full Text] [Related]  

  • 36. Implications of myocardial matrix remodeling by adipokines in obesity-related heart failure.
    Schram K; Sweeney G
    Trends Cardiovasc Med; 2008 Aug; 18(6):199-205. PubMed ID: 19185809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of phospholamban in the pathogenesis of heart failure.
    Waggoner JR; Kranias EG
    Heart Fail Clin; 2005 Jul; 1(2):207-18. PubMed ID: 17386847
    [No Abstract]   [Full Text] [Related]  

  • 38. Metabolic remodelling of the failing heart: beneficial or detrimental?
    van Bilsen M; van Nieuwenhoven FA; van der Vusse GJ
    Cardiovasc Res; 2009 Feb; 81(3):420-8. PubMed ID: 18854380
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protecting ischemic hearts by modulation of SR calcium handling.
    Tanno M; Miura T
    Cardiovasc Res; 2007 Aug; 75(3):453-4. PubMed ID: 17601516
    [No Abstract]   [Full Text] [Related]  

  • 40. Ranolazine improves diastolic dysfunction in isolated myocardium from failing human hearts--role of late sodium current and intracellular ion accumulation.
    Sossalla S; Wagner S; Rasenack EC; Ruff H; Weber SL; Schöndube FA; Tirilomis T; Tenderich G; Hasenfuss G; Belardinelli L; Maier LS
    J Mol Cell Cardiol; 2008 Jul; 45(1):32-43. PubMed ID: 18439620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.